We further showed that HSP90 dissociation with HER2 was also induced by neratinib in HER2-low breast cancer cells (Fig. S2C), similar to those reported in HER2 positive breast cancer cells [25]. This evidence concerns the gene ERBB2 and breast carcinoma.